المؤلفون: Sharma A; Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA. akshay.sharma@stjude.org., Huang S; Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Li Y; Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Brooke RJ; Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Ahmed I; Pediatric Hematology, Oncology and BMT, Children's Mercy Hospital Kansas City, Kansas City, MO, USA., Allewelt HB; Pediatric Hematology Oncology, AdventHealth for Children, Orlando, FL, USA., Amrolia P; Department of Bone Marrow Transplant, Great Ormond St Children's Hospital, London, UK., Bertaina A; Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, CA, USA., Bhatt NS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Bierings MB; Stem cell transplantation, Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands., Bies J; Pediatrics, University of North Carolina, Chapel Hill, NC, USA., Brisset C; Hemato-immunology Department, Robert Debré Hospital, GHU APHP Nord-Université de Paris, Paris, France., Brondon JE; Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA., Dahlberg A; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dalle JH; Hemato-immunology Department, Robert Debré Hospital, GHU APHP Nord-Université de Paris, Paris, France., Eissa H; Blood and Marrow Transplant and Cellular Therapeutics, Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA., Fahd M; Hemato-immunology Department, Robert Debré Hospital, GHU APHP Nord-Université de Paris, Paris, France., Gassas A; Department of Haematology and Oncology, Royal Hospital for Children, Bristol, UK., Gloude NJ; Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, CA, USA., Goebel WS; Pediatrics, Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN, USA., Goeckerman ES; Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA., Harris K; Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA., Ho R; Pediatric Hematology, Oncology and BMT, Vanderbilt University Medical Center, Nashville, TN, USA., Hudspeth MP; Pediatric Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA., Huo JS; Pediatric Cellular Therapies, Cancer and Blood Disorders, Atrium Health Levine Children's Hospital, Charlotte, NC, USA., Jacobsohn D; Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA., Kasow KA; Pediatrics, University of North Carolina, Chapel Hill, NC, USA., Katsanis E; Department of Pediatrics, University of Arizona, Tucson, AZ, USA., Kaviany S; Pediatric Hematology, Oncology and BMT, Vanderbilt University Medical Center, Nashville, TN, USA., Keating AK; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA., Kernan NA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Ktena YP; Pediatric Oncology, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Lauhan CR; Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, CA, USA., López-Hernandez G; Bone Marrow Transplant and Cell therapy Department, National Institute of Pediatrics, Ciudad de Mexico, Mexico., Martin PL; Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA., Myers KC; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Naik S; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Olaya-Vargas A; Bone Marrow Transplant and Cell therapy Department, National Institute of Pediatrics, Ciudad de Mexico, Mexico., Onishi T; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Radhi M; Pediatric Hematology, Oncology and BMT, Children's Mercy Hospital Kansas City, Kansas City, MO, USA., Ramachandran S; Oncology, Haematology, Blood and Marrow Transplantation, Child and Adolescent Health Services, Perth Children's Hospital, Nedlands, WA, Australia., Ramos K; Department of Pediatrics, University of Arizona, Tucson, AZ, USA., Rangarajan HG; Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA., Roehrs PA; Pediatric Cellular Therapies, Cancer and Blood Disorders, Atrium Health Levine Children's Hospital, Charlotte, NC, USA., Sampson ME; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Shaw PJ; Children's Hospital at Westmead, Westmead, NSW, Australia., Skiles JL; Pediatrics, Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN, USA., Somers K; Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA., Symons HJ; Pediatric Oncology, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA., de Tersant M; Hemato-immunology Department, Robert Debré Hospital, GHU APHP Nord-Université de Paris, Paris, France., Uber AN; Pediatric Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA., Versluys B; Stem cell transplantation, Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands., Cheng C; Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Triplett BM; Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2021 Dec; Vol. 56 (12), pp. 2997-3007. Date of Electronic Publication: 2021 Sep 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects , Leukemia, Myeloid, Acute*/complications, Child ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Transplantation Conditioning/adverse effects

المؤلفون: Lauhan CR; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, California., Schiff D; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, California., Gloude N; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, California.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Nov; Vol. 67 (11), pp. e28528. Date of Electronic Publication: 2020 Aug 09.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Hematopoietic Stem Cell Transplantation/*methods , Liver Neoplasms/*therapy , Lymphoma, T-Cell/*therapy , Splenic Neoplasms/*therapy , Turner Syndrome/*therapy, Adolescent ; Carboplatin/administration & dosage ; Combined Modality Therapy ; Etoposide/administration & dosage ; Female ; Humans ; Ifosfamide/administration & dosage ; Liver Neoplasms/complications ; Liver Neoplasms/pathology ; Lymphoma, T-Cell/complications ; Lymphoma, T-Cell/pathology ; Prognosis ; Splenic Neoplasms/complications ; Splenic Neoplasms/pathology ; Turner Syndrome/complications ; Turner Syndrome/pathology